The market for clinical trial supplies was estimated to be worth USD 4.3 billion in 2023-e and is expected to reach USD 8.7 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.2% The market for clinical trial supplies is driven by biopharmaceutical companies’ increasing R&D expenditures. As biopharmaceutical companies increase their R&D investments, the market is expanding significantly. These companies are demonstrating a strong focus on advancing medical innovations by conducting an increasing number of clinical trials. The safety and effectiveness of experimental products are guaranteed by stringent regulatory requirements. Outsourcing is becoming more common in the sector, giving businesses access to specialized services. Furthermore, the market is impacted by the rising incidence of illnesses, particularly rare and orphan diseases, which fuel the need for in-depth clinical research and the corresponding need for a variety of clinical trial supplies.

During the 2024–2030 forecast period, the clinical packaging, labeling, and blinding services segment is anticipated to hold a significant portion of the market. Customized packaging designs, along with compliant labeling and blinding services, are highly sought after for investigational drugs. This complies with regulatory requirements and guarantees the integrity and correct identification of trial supplies.

Health Technology Insights: Steer Health Launches AI-Powered SteerConnect for Care Access

Studies on bioavailability and bioequivalence (BA/BE), which look at how quickly and how much a drug is absorbed into the bloodstream, are crucial for the development of generic drugs. In order to guarantee comparability with the reference product, clinical trial supplies for BA/BE studies require exact formulation and production.

Clinical Research Organizations (CROs) play a vital role in outsourcing various components of clinical trials, including supply chain management, packaging, and logistics. As pharmaceutical and biopharmaceutical companies increasingly collaborate with CROs to streamline operations, the CRO segment contributes significantly to the overall market. Moreover, the trend towards outsourcing various aspects of clinical trials to CROs is gaining traction due to the advantages of expertise, cost-effectiveness, and operational efficiency.

Clinical Trial Supplies Market By End Use Industry

Asia Pacific clinical trial supplies market is anticipated to grow at a faster pace during the forecast period. The increasing emphasis on strategic initiatives such as partnerships, collaborations, and expansion, along with the growing influx of investments in the life sciences sector, is driving the growth of the clinical trial supplies markets in the region.

Health Technology Insights: Rising Health Insurance Costs Are Crippling Small Businesses Across America

The clinical trial supplies market is characterized by the presence of various small and big players. The major market players includes Almac Group, Biocair, Catalent, Eurofins Scientific, Nuvisan, Lonza Group, PCI Pharma Services, Piramal Pharma Solutions, PRA Health Sciences, Sharp Services, and Thermo Fisher Scientific amongst others.  

Major market players are swiftly embracing advanced technologies to enhance clinical trial supplies operations and bolster their competitive stance through strategic initiatives, including mergers, acquisitions, and the introduction of new products. For instance, In August 2022, Marken acquired Bomi Group to bolster growth in healthcare logistics. This acquisition expands the company’s global presence and enhances cold chain capabilities in major European and Latin American markets.

TRENDING REPORTS

Health Technology Insights: Finland Launches Pilot Medical Technology to Speed Patient-Friendly Tech Entry

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

About  Intent Market Research™

Intent Market Research (IMR) is a market research firm dedicated to providing unique, data-driven insights that support sustainable and inclusive business growth. We specialize in comprehensive market research reports and consulting services across diverse industries including chemicals, healthcare, automotive, energy, packaging, and semiconductor & electronics.

Our approach centers on delivering transformative market intelligence through syndicated reports, custom research, and strategic consulting services. We work closely with clients to develop tailored solutions that address unique business challenges, offering quantifiable market insights and forward-looking strategies. Our team of expert analysts and consultants combines cutting-edge competencies with a robust research methodology to help businesses explore new markets, develop innovative products, and uncover growth opportunities.

At IMR, we are committed to ethical standards and compliance, conducting research with transparency and integrity. We prioritize data privacy, maintain strict confidentiality, and adhere to industry regulations. Our goal is to empower businesses with comprehensive, fact-based insights that drive sustainable advantages and meaningful organizational change.

To find out more, visit Intent Market Research™ or follow us on LinkedIn. 

Contact:
Mr. Jay Kumar
Intent Market Research

1846 E Innovation Park DR Site
100 ORO Valley
AZ 85755

USA: +1 463-583-2713
Email: sales@intentmarketsearch.com